Home › Funds › MPM BioImpact LLC › DRUG

MPM BioImpact LLC position in DRUG

BRIGHT MINDS BIOSCIENCES INC · Health Care

MPM BioImpact LLC reported holding 202,114 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 0.87% of its reported portfolio and ranking #33 among its reported holdings. MPM BioImpact LLC has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)202.11K sh
Reported value held$14.19M
Portfolio Weight0.87%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's DRUG position evolved

MPM BioImpact LLC first disclosed a stake in DRUG in Q4 2025 at 230,147 shares (US$18.0M). Across 3 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 202,114 shares valued at US$14.2M — a reduction of -10,061 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 230.15K $17.96M New
Q1 2026 212.18K $15.48M Reduce
Q2 2026 202.11K $14.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRUG and 13F data

DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 77 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vivo Capital, LLC (US$39.1M), Vestal Point Capital, LP (US$38.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRUG

All DRUG fund holders →

FAQ

How long has MPM BioImpact LLC held DRUG?

MPM BioImpact LLC has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is MPM BioImpact LLC's current position in DRUG?

As of Q2 2026, MPM BioImpact LLC holds 202.11K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $14.19M, representing 0.87% of its reported portfolio and ranking #33.

Has MPM BioImpact LLC been buying or selling DRUG?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in DRUG.

Which other funds hold DRUG?

Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vivo Capital, LLC, Vestal Point Capital, LP, among 77 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.